Support: 888-992-3836
|
NewsWire
|
Home
|
Login / Register
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
Hot!
Breakout Boards
Follow Feed
iHub My Stocks Activity
Ticker Buzz Cloud
Most Read
Most Posted
Most Followed Members
Recent News
News By Market
Active Boards
Site Stats
New Boards
Cannabis Stocks
Top PlusOneCoin Posters
Tools
Data Tools >
Charts
Trader Alerts
Trades
Portfolio
Top Lists
Price & News Alerts
Commodities
NewsWire
More Tools >
Newsletters
InvestorsHub Daily
My Image Gallery
Advanced Search
All News
Stock Screener
News Filter
Live Charts
Live News
Live Desktop
Forex Prices
Commodities
Educational Channel
Follow Feed
News Scanner
Crypto
Top Cryptocurrencies
PLUS1 Info & Faucet
Top Tokens
New Cryptocurrencies
Crypto Converter
Streamer
Level 2
Home
>
Boards
>
US Listed
>
Biotechs
>
Hemispherx BioPharma (HEB)
Add HEB Price Alert
Hide Sticky
Hide Intro
Moderator:
Search This Board:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
Last Post:
11/5/2020 10:36:39 AM
-
Followers:
214
- Board type:
Free
- Posts Today:
0
Hemispherx BioPharma (HEB)
Stephen Thorpe has been added as Chief Operating Officer – HEMISPHERX BIOPHARMA INC
Mr Thorpe with his background in Building Medical equipment and many years in production automation will be an asset to us. Factor in his extreme devotion to dogs and how he cannot be bullied off a life long meat and potato diet, he has everytrhing you can ask for in a guy to lean on for technical advice and know how.
WILLIAM CARTER – HEMISPHERX BIOPHARMA INC
R. WILLIAM CARTER has served as Chief Scientific Officer of Hemispherx Biopharma, Inc., since May 1989, the Chairman of the company's Board of Directors since January 1992, the company's Chief Executive Officer since July 1993, the company's President since April 1995, and a Director since 1987. He is the co-inventor of Ampligen', joined the company in 1978, and from 1987 to 1988, he served as the company's Chairman. Dr. Carter was a leading innovator in the development of human interferon for a variety of treatment indications including various viral diseases and cancer. In this context, he received the first FDA approval to initiate clinical trials on a beta interferon product manufactured in the US under his supervision. From 1985 to October 1988, Dr. Carter served as the company's Chief Executive Officer and Chief Scientist. He received his MD degree from Duke University and underwent his post-doctoral training at the National Institutes of Health and Johns Hopkins University. Dr. Carter also served as Professor of Neoplastic Diseases at Hahnemann Medical University, a position he held from 1980 to 1998. He also served as Director of Clinical Research for Hahnemann Medical University's Institute for Cancer and Blood Diseases, and as a Professor at Johns Hopkins School of Medicine and the State University of New York at Buffalo. He is a Board certified physician and author of more than 200 scientific articles, including the editing of various textbooks on anti-viral and immune therapy
PIPELINE.
Commercial Products
Country: USA
PRODUCT NAME
CATEGORY
COMMERICAL STATUS
Alferon N Injection®
Genital HPV (condylomata acuminata)
Sales anticipated to resume upon successful pre-approval inspection and supplemental approval by FDA
Country: Argentina
PRODUCT NAME
CATEGORY
COMMERICAL STATUS
Alferon N Injection®
Genital HPV (condylomata acuminata)
Approved. Launch pending manufacturing approval
Alferon N Injection®
Refractory to Recombinant IFN
Approved. Launch pending manufacturing approval
Rintatolimod (U.S. Tradename: Ampligen®)
Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Approved. Launch pending
Product Candidate
Country
Indication
Ampligen®
USA
CFS/ME
Ampligen®
USA
HIV
Ampligen®
USA
Metastatic Melanoma
Ampligen®
USA
Renal Cell Carcinoma
Ampligen®
European Union
Ebola Virus Disease
Alferon N Injection®
European Union
MERS
HEB
Current Price
Volume:
Bid
Ask
Day's Range
HEB Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
Post New Msg
Follow Board
My Stocks (136)
Hide Intro
View Posters
HEB Poststream
Bans (2)
Hide Quote
Filter Disabled
Post
Subject
#15662
Hemispherx Biopharma (HEB)
mick
11/05/20 10:36:39 AM
#15661
I liked the original name better lol. Still
Richard2
11/05/20 09:30:40 AM
#15660
Hemispherx Biopharma (HEB) NOW AIM
mick
04/05/20 04:08:00 PM
#15659
Thank you Richard, I couldn't seem to find
deniseann
02/05/20 11:37:21 AM
#15658
‘AIM’ is the new ticker.
Richard2
02/05/20 04:43:25 AM
#15657
No, the company changed its name and ticker.
Richard2
02/05/20 04:42:13 AM
#15656
Is this still a real stock..?
deniseann
01/30/20 12:25:12 PM
#15655
Buying all i can it may be a
lowfloatwayne
11/06/19 06:36:32 PM
#15654
This drug could be huge in the me/cfs
Richard2
10/28/19 11:17:30 AM
#15653
They need cash so they can hit their
LW89
08/29/19 05:42:17 PM
#15652
Their voting now to raise the share count
lowfloatwayne
08/28/19 09:00:51 AM
#15651
Acusphere has twice as many shares moves ez
lowfloatwayne
08/26/19 09:11:15 PM
#15650
this is just sad. pure sad
cspratt15139
08/18/19 08:56:54 AM
#15649
Ok their not adding shares could be a
lowfloatwayne
08/05/19 09:35:14 PM
#15648
they do this to themselves
cspratt15139
07/23/19 08:36:48 PM
#15647
So they rs to 2.2m shares then dilute
lowfloatwayne
07/22/19 09:48:54 PM
#15646
strong buy here. Bottom bouncer.
aristotelisonassis
07/17/19 02:06:48 PM
#15645
Hope everyone is enjoying there weekend. Stay safe
cspratt15139
06/22/19 04:18:43 PM
#15644
Ampligen is picking up steam
cspratt15139
06/16/19 04:15:04 PM
#15643
Fully funded trial up to 45-people, low float,
bleu22
06/16/19 03:56:04 PM
#15642
Going higher
cspratt15139
06/15/19 08:10:39 PM
#15641
LOL..Can't even wait a few days to reward
420man
06/13/19 06:49:07 PM
#15640
They don’t even have options laid out yet. WTF
bleu22
06/12/19 09:37:18 PM
#15639
News: $HEB
Hemispherx Biopharma Announces First Patient Treated
whytestocks
06/12/19 04:00:54 PM
#15638
There's your RS... Let the shorting begin!!!
420man
06/11/19 12:11:29 PM
#15637
Split coming
cspratt15139
06/10/19 07:30:37 PM
#15636
.05
420man
06/07/19 06:31:37 PM
#15635
How low will it go before the RS
Golden_Cross
06/02/19 04:42:26 AM
#15634
News: $HEB
Hemispherx Biopharma Stockholders Approve Reverse Stock Split
whytestocks
05/31/19 10:30:39 AM
#15633
When is the rs
cspratt15139
05/29/19 06:56:58 AM
#15632
https://www.mrknewsroom.com/news-release/oncology/merck-provides-update-phase-3-
hebbeke47
05/21/19 04:02:56 AM
#15631
They have investors after the rs or people
carldfw
05/18/19 08:20:20 PM
#15630
HEB Daily Chart:
Golden_Cross
05/17/19 07:10:03 PM
#15629
News: $HEB
Hemispherx Links Stanford's ME/CFS Diagnostic to
whytestocks
05/06/19 09:50:39 AM
#15628
HEB on High Alert
Golden_Cross
05/06/19 09:10:15 AM
#15627
WOW that's insane!!!! Thanks for sharing the actual
tknuncle
05/03/19 08:53:08 PM
#15626
So the warrant exercise price has been reduced
420man
05/03/19 07:41:19 PM
#15625
As I said several times, no value here,
pberger
05/03/19 07:56:51 AM
#15624
* * $HEB Video Chart 05-02-2019 * *
ClayTrader
05/02/19 04:41:54 PM
#15623
sinking fast here
Golden_Cross
05/02/19 10:17:42 AM
#15622
price of warrants reduced to .15 bearish
nokomis
05/02/19 10:14:17 AM
#15621
This pure CRAP is now below the "good
pberger
05/02/19 09:53:20 AM
#15620
Nasty... Looking to buy back in on a
Golden_Cross
05/02/19 09:09:15 AM
#15619
* * $HEB Video Chart 05-01-2019 * *
ClayTrader
05/01/19 04:57:00 PM
#15618
Nice news today!
Golden_Cross
05/01/19 09:48:46 AM
#15617
Dilution pure....
Zarate69
05/01/19 09:48:28 AM
#15616
Where are all these shares coming from? It
tknuncle
05/01/19 09:42:45 AM
#15615
Where is the news? Thanks
aidytrader
05/01/19 09:23:21 AM
#15614
$heb..huge news out today..shorts scrambling premarket...
TommyBoyTrader9460
05/01/19 09:13:11 AM
#15613
26s!!
JJGl
05/01/19 08:58:03 AM
Post
Subject
Post New Msg
Follow Board
My Stocks (136)
Hide Intro
View Posters
HEB Poststream
Bans (2)
Hide Quote
Filter Disabled
Balance Available:
0
Get FREE PlusOneCoins!
© 2022 InvestorsHub.com, Inc.
Consent Preferences